MYC and breast carcinoma: As shown in Figure 8C,D, EP significantly reduces the expression of BCL-XL (P < 0.001), as well as that of Cyclin D1 (P < 0.05) and c-Myc (P < 0.001), which are signaling molecules involved in cell cycle progression and proliferation in breast cancer cells.